Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 10, 2014 - Issue 10
Submit an article Journal homepage
1,112
Views
11
CrossRef citations to date
0
Altmetric
Editorials

Toll like receptors: a new hope on the horizon to treat multiple sclerosis

Maziar GoosheResearch Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran 14194, Iran;Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
,
Ali Reza AleyasinResearch Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran 14194, Iran;Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran
,
Amir Hossein AbdolghaffariPharmacology and Applied Medicine, Department of Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran;International Campus, ICTUMS, Tehran University of Medical Sciences, Tehran, Iran
&
Nima RezaeiResearch Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran 14194, Iran;Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran;Department of Infection and Immunity, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UKCorrespondence[email protected]
Pages 1277-1279 | Published online: 27 Aug 2014

References

  • DeLuca J, Nocentini U. Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis. NeuroRehabilitation 2011;29(3):197-219
  • Dutta R, Trapp BD. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 2011;93(1):1-12
  • Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008;31:247-69
  • Castro-Borrero W, Graves D, Frohman TC, et al. Current and emerging therapies in multiple sclerosis: a systematic review. Ther Adv Neurol Disord Therapeutic advances in neurological disorders 2012;5(4):205-20
  • Steinman L. Immunology of relapse and remission in multiple sclerosis. Annu Rev Immunol 2014;32:257-81
  • Rezaei N. Therapeutic targeting of pattern-recognition receptors. Int Immunopharmacol 2006;6(6):863-9
  • Akira S. Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci 2009;85(4):143-56
  • Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4(7):499-511
  • Hedayat M, Takeda K, Rezaei N. Prophylactic and therapeutic implications of toll like receptor ligands. Med Res Rev 2012;32(2):294-325
  • Zuany-Amorim C, Hastewell J, Walker C. Toll-like receptors as potential therapeutic targets for multiple diseases. Nat Rev Drug Discov 2002;1(10):797-807
  • Gooshe M, Abdolghaffari AH, Gambuzza ME, Rezaei N. The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes. Rev Neurosci 2014. [Epub ahead of print]
  • Jasani B, Navabi H, Adams M. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer. Vaccine 2009;27(25-26):3401-4
  • Touil T, Fitzgerald D, Zhang GX, et al. Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol 2006:177(11):7505-9
  • Henrick BM, Nag K, Yao XD, et al. Milk matters: soluble toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. PLoS One 2012;7(7):e40138
  • Hayashi T, Gray CS, Chan M, et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Proc Natl Acad Sci USA 2009;106(8):2764-9
  • Toshchakov VY, Vogel SN. Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions. Expert Opin Biol Ther 2007;7(7):1035-50
  • Antosz H, Choroszynska D. [Negative regulation of toll-like receptor signalling]. Postepy higieny i medycyny doswiadczalnej (Online) 2013;67:339-50
  • Filippini G, Del Giovane C, Vacchi L, et al. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis. Cochrane Database Syst Rev 2013;6: Cd008933
  • Ciccone A, Beretta S, Brusaferri F, et al. Corticosteroids for the long-term treatment in multiple sclerosis. Cochrane Database Syst Rev 2008(1): Cd006264

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.